Glycerin Derived Tears Segment has the Largest Share of Type in the Europe Artificial Tears Market during 2021-2028.
According to a new market research study on “Europe Artificial Tears Market to 2028 - COVID-19 Impact and Regional Analysis and Forecast by Type, Delivery Mode, and Application,” is expected to reach US$ 816.9 million by 2028 from US$ 546.0 million in 2021. The market is estimated to grow at a CAGR of 5.9% from 2021 to 2028. The report provides trends prevailing in the Europe Artificial tears market along with the drivers and restraints pertaining to the market growth. The growth of this market is estimated to grow owing to key driving factors such as the rising incidence of dry eye and the growing older population are the key factors driving the market growth. However, the market is expected experiencing slow growth during the forecast period owing to the poor accessibility to eye care services in countries.
More time indoors with the central heating on and staring at a screen for long periods are both factors that are thought to have led to an increase of Dry Eye Syndrome in the COVID-19 pandemic. According to studies, one in every four persons in the UK (about 13 million adults) suffers from Dry Eye, a condition that causes red, itchy, and fatigued eyes. Eye strain, another eye issue that has become more widespread in line with an increase in time spent staring at screens, can exacerbate these symptoms. Excessive screen time or failing to give one’s eyes regular rests are two prominent causes - and one only needs to look at some of the statistics to understand how the strain of ‘virtual living' is affecting one’s eyes. According to research, UK adults purchased up to 21 million new digital devices during the lockdown, including TVs, games consoles, and laptops, with another study by Zen Internet finding that internet usage in the UK surged by 78% year-on-year in 2020.Other known causes of Dry Eye include prolonged exposure to air conditioning or heating, long-term contact lens wear, and as a side effect of some drugs. Hormone abnormalities may also be to reason. Women going through perimenopause and menopause may find that their eyes become dryer, which is connected to hormonal changes caused by estrogen levels dropping. These factors had a potential impact on the Europe artificial tears market.
The market for Artificial tears market is segmented into type, delivery mode, and application. Based on type, the artificial tears market is segmented into glycerin derived tears, cellulose derived tears, oil-based emulsion tears, polythylene glycol-based tears, sodium hyaluronate based artificial tears, and propylene glycol-based tears. In 2020, glycerin derived tears segment accounted for the largest share of the market owing to their easy availability and ability to keep eyes moist for long. Glycerin is a humectant, as well as a demulcent and lubricant. Glycerin also has the benefit of promoting epithelial cell growth and reducing the harmful effects of high osmolarity on the ocular surface. Povidone is a lipid that binds to the tear film's existing oil layer, thickening it and reducing evaporation.
Johnson and Johnson Services, Inc. Alcon Inc. OASIS Medical, AbbVie Inc. Bayer AG, Prestige Consumer Healthcare Inc. Santen Pharmaceutical Co. Ltd. and Bausch Health Companies Inc. are among the leading companies in the Europe Artificial tears market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in February 2021, Bausch + Lomb launched Alaway® Preservative Free (ketotifen fumarate ophthalmic solution 0.035%) antihistamine eye drops, the first and only over the counter (OTC) preservative-free antihistamine eye itch relief drop approved by the U.S. Food and Drug Administration.
According to a new market research study on “Europe Artificial Tears Market to 2028 - COVID-19 Impact and Regional Analysis and Forecast by Type, Delivery Mode, and Application,” is expected to reach US$ 816.9 million by 2028 from US$ 546.0 million in 2021. The market is estimated to grow at a CAGR of 5.9% from 2021 to 2028. The report provides trends prevailing in the Europe Artificial tears market along with the drivers and restraints pertaining to the market growth. The growth of this market is estimated to grow owing to key driving factors such as the rising incidence of dry eye and the growing older population are the key factors driving the market growth. However, the market is expected experiencing slow growth during the forecast period owing to the poor accessibility to eye care services in countries.
More time indoors with the central heating on and staring at a screen for long periods are both factors that are thought to have led to an increase of Dry Eye Syndrome in the COVID-19 pandemic. According to studies, one in every four persons in the UK (about 13 million adults) suffers from Dry Eye, a condition that causes red, itchy, and fatigued eyes. Eye strain, another eye issue that has become more widespread in line with an increase in time spent staring at screens, can exacerbate these symptoms. Excessive screen time or failing to give one’s eyes regular rests are two prominent causes - and one only needs to look at some of the statistics to understand how the strain of ‘virtual living' is affecting one’s eyes. According to research, UK adults purchased up to 21 million new digital devices during the lockdown, including TVs, games consoles, and laptops, with another study by Zen Internet finding that internet usage in the UK surged by 78% year-on-year in 2020.Other known causes of Dry Eye include prolonged exposure to air conditioning or heating, long-term contact lens wear, and as a side effect of some drugs. Hormone abnormalities may also be to reason. Women going through perimenopause and menopause may find that their eyes become dryer, which is connected to hormonal changes caused by estrogen levels dropping. These factors had a potential impact on the Europe artificial tears market.
The market for Artificial tears market is segmented into type, delivery mode, and application. Based on type, the artificial tears market is segmented into glycerin derived tears, cellulose derived tears, oil-based emulsion tears, polythylene glycol-based tears, sodium hyaluronate based artificial tears, and propylene glycol-based tears. In 2020, glycerin derived tears segment accounted for the largest share of the market owing to their easy availability and ability to keep eyes moist for long. Glycerin is a humectant, as well as a demulcent and lubricant. Glycerin also has the benefit of promoting epithelial cell growth and reducing the harmful effects of high osmolarity on the ocular surface. Povidone is a lipid that binds to the tear film's existing oil layer, thickening it and reducing evaporation.
Johnson and Johnson Services, Inc. Alcon Inc. OASIS Medical, AbbVie Inc. Bayer AG, Prestige Consumer Healthcare Inc. Santen Pharmaceutical Co. Ltd. and Bausch Health Companies Inc. are among the leading companies in the Europe Artificial tears market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in February 2021, Bausch + Lomb launched Alaway® Preservative Free (ketotifen fumarate ophthalmic solution 0.035%) antihistamine eye drops, the first and only over the counter (OTC) preservative-free antihistamine eye itch relief drop approved by the U.S. Food and Drug Administration.
The report segments the Europe Artificial Tears market as follows:
By Type
- Glycerin Derived Tears
- Cellulose Derived Tears
- Oil-based Emulsion Tears
- Polythylene Glycol Based Tears
- Sodium Hyaluronate Based Artificial Tears
- Propylene Glycol Based Tears
By Delivery Mode
- Eye Drops
- Ointments
By Application
- Dry Eyes Treatment
- Contact Lenses Moisture
By Country
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
Reasons to buy:
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe artificial tears market
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Europe artificial tears market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the artificial tears market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
Table of Contents
1. Introduction
3. Research Methodology
4. Europe Artificial Tears Market - Market Landscape
5. Europe Artificial Tears Market - Key Market Dynamics
6. Artificial Tears Market - Europe Analysis
7. Europe Artificial Tears Market Analysis and Forecasts To 2028 - By Type
8. Europe Artificial Tears Market Analysis and Forecasts To 2028 - By Delivery Mode
9. Europe Artificial Tears Market Analysis and Forecasts to 2028 - By Application
10. Artificial Tears Market Revenue and Forecasts to 2028 - Geographical Analysis
11. Impact Of COVID-19 Pandemic on Europe Artificial Tears Market
12. Industry Landscape
13. COMPANY PROFILES
14. Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Johnson and Johnson Services, Inc.
- Alcon Inc.
- OASIS Medical
- AbbVie Inc.
- Bayer AG
- Prestige Consumer Healthcare Inc.
- Santen Pharmaceutical Co., Ltd.
- Bausch Health Companies Inc.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 131 |
Published | July 2021 |
Forecast Period | 2021 - 2028 |
Estimated Market Value ( USD | $ 546 Million |
Forecasted Market Value ( USD | $ 816.9 Million |
Compound Annual Growth Rate | 5.9% |
Regions Covered | Europe |